查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591849

組織學/細胞學市場：按測試類型、產品類型、測試類型、最終用戶 - 2025-2030 年全球預測

Histology & Cytology Market by Type of Examination (Cytology, Histology), Product (Consumable & Reagents, Instruments & Analysis Software System), Test Type, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年組織學和細胞學市場價值為208.6億美元，預計到2024年將達到238.1億美元，複合年成長率為14.25%，到2030年將達到530.1億美元。

組織學和細胞學是生命科學的重要領域，專注於細胞和組織樣本的顯微鏡檢查以研究疾病過程、結構和功能。該領域的需求在於其在疾病診斷中的重要作用，特別是癌症、感染疾病和自體免疫疾病。應用範圍廣泛，包括用於診斷目的的臨床環境、闡明疾病機制的研究機構以及用於藥物開發的製藥公司。最終用途範圍包括醫院、診所、學術研究機構和生技公司，凸顯了其在醫療保健和生物醫學研究中的巨大效用。市場成長受到全球癌症和其他慢性疾病盛行率上升的顯著影響，推動了對組織學和細胞學檢測的診斷準確性和精確度的需求。此外，樣本製備自動化、數位病理學和人工智慧影像分析等技術進步有助於更快、更準確的診斷，提供潛在的成長機會。然而，它面臨著先進設備高成本、監管要求嚴格以及缺乏熟練專業人員等挑戰，在一定程度上限制了市場的成長。新興市場充滿商機，醫療基礎設施不斷擴大，個人化醫療越來越受歡迎。公司可以透過投資具有成本效益的創新和技術來簡化工作流程並提高診斷能力來利用這些優勢。創新的關鍵領域包括開發用於就地檢驗的可攜式設備、提高檢測靈敏度和特異性，以及建立用於大規模分析的強大資料管理系統。該市場充滿活力，其特點是旨在提高研究能力和擴大產品系列的整合和聯盟。為了獲得成功，公司應專注於協作研發，透過經濟實惠的解決方案解決高成本障礙，並確保遵守監管標準以獲得競爭優勢。

主要市場統計
基準年[2023] 208.6億美元
預測年份 [2024] 238.1億美元
預測年份 [2030] 530.1億美元
複合年成長率（%） 14.25%

市場動態：針對快速發展的組織學和細胞學市場揭示的關鍵市場見解

供應和需求的動態相互作用正在改變組織學和細胞學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 慢性病診斷的採用率提高
    • 病理實驗室標準化進展
    • 癌症篩檢和實驗室檢查的優惠報銷制度
  • 市場限制因素
    • 由於測試成本上升導致產品認知度下降
  • 市場機會
    • 繼續採用專門用於細胞層面觀察的測試
    • 業界持續研發拓展多種疾病診斷應用
  • 市場挑戰
    • 正確的診斷需要大量樣本

波特的五力：駕馭組織學與細胞學市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解組織學和細胞學市場的外部影響

外部宏觀環境因素在塑造組織學和細胞學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解組織學/細胞學市場的競爭狀況

對組織學和細胞學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，使他們的公司能夠應對日益激烈的競爭。

FPNV定位矩陣組織學和細胞學市場供應商的績效評估

FPNV定位矩陣是評估組織學和細胞學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，規劃組織學和細胞學市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，組織學和細胞學市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病診斷的採用率提高
      • 病理實驗室標準化進展
      • 癌症篩檢和實驗室檢查的優惠報銷制度
    • 抑制因素
      • 產品認知度下降與測試成本上升
    • 機會
      • 繼續引入專門的細胞水平觀察測試
      • 產業相關人員不斷進行研究和開發活動，以增加其在各種疾病診斷中的應用。
    • 任務
      • 正確的診斷需要大量樣本
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第 6 章按類型分類的組織學/細胞學市場測試

  • 細胞學
    • 乳癌
    • 子宮頸癌
  • 組織學

第 7 章組織學/細胞學市場：依產品

  • 耗材和試劑
  • 儀器和分析軟體系統

第 8 章按測試類型分類的組織學/細胞學市場

  • 流式細胞技術
  • 顯微鏡檢查
  • 分子遺傳學

第 9 章組織學/細胞學市場：依最終使用者分類

  • 臨床診斷
  • 診所
  • 醫院
  • 生命科學研究機構

第10章：美洲的組織學與細胞學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太組織學/細胞學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的組織學/細胞學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Medimeas Instruments
  • Merck KGaA
  • PerkinElmer Inc.
  • Polysciences, Inc.
  • StatLab Medical Products
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare
Product Code: MRR-A339DAEFAEB0

The Histology & Cytology Market was valued at USD 20.86 billion in 2023, expected to reach USD 23.81 billion in 2024, and is projected to grow at a CAGR of 14.25%, to USD 53.01 billion by 2030.

Histology and cytology are essential branches of life sciences focused on the microscopic examination of cells and tissue samples to study disease processes, structure, and functionality. The necessity of this domain lies in its critical role in diagnosing diseases, particularly cancer, infectious diseases, and autoimmune disorders. Applications span across clinical settings for diagnostic purposes, research institutes for understanding disease mechanisms, and pharmaceutical companies for drug development. The end-use scope comprises hospitals, clinics, academic and research institutions, and biotechnology firms, highlighting the vast utility in healthcare and biomedical research. Market growth is significantly influenced by the rising prevalence of cancer and other chronic diseases globally, which drives the demand for diagnostic accuracy and precision in histological and cytological assays. Moreover, technological advancements such as automation in sample preparation, digital pathology, and AI-powered image analysis offer potential growth opportunities, facilitating faster and more accurate diagnostics. However, the market faces challenges such as high costs associated with advanced instruments, strict regulatory requirements, and a shortage of skilled professionals, which restrict growth to an extent. Opportunities abound in emerging markets where healthcare infrastructure is expanding, and personalized medicine is gaining traction. Businesses can capitalize on these by investing in cost-effective innovations and technologies that streamline workflow and improve diagnostic capabilities. Key areas for innovation include the development of portable devices for point-of-care testing, enhancing the sensitivity and specificity of assays, and establishing robust data management systems for large-scale analysis. The market is dynamic, characterized by consolidation and partnerships aimed at advancing research capabilities and expanding product portfolios. To thrive, companies should focus on collaborative research and development, addressing the high cost barrier through affordable solutions, and ensuring compliance with regulatory standards to gain a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 20.86 billion
Estimated Year [2024] USD 23.81 billion
Forecast Year [2030] USD 53.01 billion
CAGR (%) 14.25%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Histology & Cytology Market

The Histology & Cytology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption in chronic disease diagnostics
    • Growing standardization of pathological laboratories
    • Favorable reimbursement schemes for cancer screening and laboratory testing
  • Market Restraints
    • Reduced awareness of the product coupled with high cost of tests
  • Market Opportunities
    • Ongoing adoption of specialized tests for cellular level observations
    • Constant research and development activities among industry players to increase its application in diagnosis of several diseases
  • Market Challenges
    • Need for large amount of sample for appropriate diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Histology & Cytology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Histology & Cytology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Histology & Cytology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Histology & Cytology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Histology & Cytology Market

A detailed market share analysis in the Histology & Cytology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Histology & Cytology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Histology & Cytology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Histology & Cytology Market

A strategic analysis of the Histology & Cytology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Histology & Cytology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson & Company, Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc., Koninklijke Philips N.V., Medimeas Instruments, Merck KGaA, PerkinElmer Inc., Polysciences, Inc., StatLab Medical Products, Sysmex Corporation, Thermo Fisher Scientific, Inc., and Trivitron Healthcare.

Market Segmentation & Coverage

This research report categorizes the Histology & Cytology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type of Examination, market is studied across Cytology and Histology. The Cytology is further studied across Breast Cancer and Cervical Cancer.
  • Based on Product, market is studied across Consumable & Reagents and Instruments & Analysis Software System.
  • Based on Test Type, market is studied across Flow Cytometry, Microscopy, and Molecular Genetic.
  • Based on End-user, market is studied across Clinical Diagnostics, Clinics, Hospitals, and Life Sciences Research Institutions.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption in chronic disease diagnostics
      • 5.1.1.2. Growing standardization of pathological laboratories
      • 5.1.1.3. Favorable reimbursement schemes for cancer screening and laboratory testing
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced awareness of the product coupled with high cost of tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing adoption of specialized tests for cellular level observations
      • 5.1.3.2. Constant research and development activities among industry players to increase its application in diagnosis of several diseases
    • 5.1.4. Challenges
      • 5.1.4.1. Need for large amount of sample for appropriate diagnosis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Histology & Cytology Market, by Type of Examination

  • 6.1. Introduction
  • 6.2. Cytology
    • 6.2.1. Breast Cancer
    • 6.2.2. Cervical Cancer
  • 6.3. Histology

7. Histology & Cytology Market, by Product

  • 7.1. Introduction
  • 7.2. Consumable & Reagents
  • 7.3. Instruments & Analysis Software System

8. Histology & Cytology Market, by Test Type

  • 8.1. Introduction
  • 8.2. Flow Cytometry
  • 8.3. Microscopy
  • 8.4. Molecular Genetic

9. Histology & Cytology Market, by End-user

  • 9.1. Introduction
  • 9.2. Clinical Diagnostics
  • 9.3. Clinics
  • 9.4. Hospitals
  • 9.5. Life Sciences Research Institutions

10. Americas Histology & Cytology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Histology & Cytology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Histology & Cytology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Becton, Dickinson & Company
  • 4. Danaher Corporation
  • 5. F. Hoffmann-La Roche Ltd.
  • 6. Hologic, Inc.
  • 7. Koninklijke Philips N.V.
  • 8. Medimeas Instruments
  • 9. Merck KGaA
  • 10. PerkinElmer Inc.
  • 11. Polysciences, Inc.
  • 12. StatLab Medical Products
  • 13. Sysmex Corporation
  • 14. Thermo Fisher Scientific, Inc.
  • 15. Trivitron Healthcare

LIST OF FIGURES

  • FIGURE 1. HISTOLOGY & CYTOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. HISTOLOGY & CYTOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. HISTOLOGY & CYTOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. HISTOLOGY & CYTOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HISTOLOGY & CYTOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HISTOLOGY & CYTOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY HISTOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CONSUMABLE & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY INSTRUMENTS & ANALYSIS SOFTWARE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY MOLECULAR GENETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL HISTOLOGY & CYTOLOGY MARKET SIZE, BY LIFE SCIENCES RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY TYPE OF EXAMINATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY CYTOLOGY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM HISTOLOGY & CYTOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. HISTOLOGY & CYTOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 235. HISTOLOGY & CYTOLOGY MARKET, FPNV POSITIONING MATRIX, 2023